Silanediol protease inhibitors: From conception to validation

被引:123
作者
Sieburth, SM
Chen, CA
机构
[1] Temple Univ, Dept Chem, Rosemont, PA 19010 USA
[2] Lundbeck Res USA Inc, Dept Chem, Paramus, NJ 07652 USA
关键词
drug design; hydrolases; inhibitors; peptidomimetics; proteases; silanes; silicon;
D O I
10.1002/ejoc.200500508
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Silanediols are isosteric with the unstable hydrated carbonyl group, but are most commonly associated with polymerization to give silicone polymers. Placement of a silanediol in a dipeptide analogue yields a new kind of nonhydrolyzable transition-state-analogue protease inhibitor. Both metallo and aspartic protease inhibitors have been prepared using silanediols, with enzyme inhibition in the low nanomolar range. Structure-activity comparisons with known inhibitors, efficacy in whole cell assays, and a crystal structure of a sitanediol inhibitor bound to the thermolysin active site establish these silanediol inhibitors as effective and predictable new protease inhibitor tools. Recent chemistry developments have led to efficient and streamlined preparation of these inhibitors. ((c) Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2006).
引用
收藏
页码:311 / 322
页数:12
相关论文
empty
未找到相关数据